Studies have also shown increased immunogenicity in STS with the use of RT, however, there may be significant biological heterogeneity with regard to immunogenicity and radiosensitivity between DDLPS and other histologies, and additional prospective data will help elucidate more nuanced pathologic response and survival differences for patients undergoing combination NIT/RT [ 34 , 35 ].
← all excerpts
Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis.
1
—
—